Dr. Bayram is a medical doctor from Turkey, who earned his medical degree from Istanbul University- Cerrahpasa School of Medicine. After finishing medical school, he worked as a General Practitioner in Turkey and gained clinical experience at UCLA, Cleveland Clinic, and Tufts Medical Center. Dr. Bayram has been involved in several projects at Mellins Lab, focusing primarily on studying Natural Killer (NK) cells in Pediatric Acute-onset Neuropsychiatric Syndrome (PANS). He conducted perforin assays as part of the PANS NK study, aiming to understand the differences between PANS patients and healthy controls. Dr. Bayram has a keen interest in Rheumatology and Immunology, with aspirations to specialize as a rheumatologist in the future.

Boards, Advisory Committees, Professional Organizations

  • Member, American College of Rheumatology (2023 - Present)

Professional Education

  • Doctor of Medicine, Istanbul University (2022)
  • 2022, Cerrahpasa School of Medicine, Medicine

Stanford Advisors

  • Mark Kay, Postdoctoral Faculty Sponsor

All Publications

  • Is it possible to predict the pCR with CBC? A commentary on "correlation analysis of lymphocyte-monocyte ratio with pathological complete response and clinical prognosis of neoadjuvant chemotherapy in patients with breast cancer" by Meng et al. Translational oncology Tanrıkulu Şimşek, E., Bayram, B., Yıldırım, A., Eşkazan, A. E. 2022; 20: 101403

    View details for DOI 10.1016/j.tranon.2022.101403

    View details for PubMedID 35339031

    View details for PubMedCentralID PMC8957052